Genmab: Revenue may exceed DKK 20bn in 2024

Genmab expects revenue in the range of DKK 18.7 - 20.5bn this year. 
Genmab CEO Jan van der Winkel. | Photo: Gregers Tycho
Genmab CEO Jan van der Winkel. | Photo: Gregers Tycho

Genmab expects that the company’s revenue in 2024 can grow by 19% and land in the range of DKK 18.7 to 20.5bn (USD 2.69-2.95bn).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading